Table 1 Main characteristics and functional variables of the study subjects
Control subjects (n = 7) Mean (SD) [95% CI]COPD patients (n = 19) Mean (SD) [95% CI]Statistical data Mean difference [95% CI], p value
Age (y)63 (8) [52 to 74]64 (8) [61 to 68]−1 [−12 to +9], p = 0.742
BMI (kg/m2)28 (1.7) [25.8 to 30]22.5 (5.2) [20 to 25]+5.5 [+2.5 to +8.4], p = 0.001
FFMI (kg/m2)19.1 (1.2) [17.6 to 20.6]16 (2.7) [14.6 to 17.4]+3.1 [+1.3 to +4.9], p = 0.002
FEV1 (% pred)110 (18) [87 to 134]33 (13) [27 to 40]+77 [+54 to +100], p<0.0001
FVC (% pred)100 (12) [85 to 114]69 (19) [60 to 78]+31 [+16 to +46], p = 0.001
RV (%)112 (1) [109 to 115]202 (50) [178 to 226]−89 [−113 to −65], p<0.0001
TLC (% pred)104 (4) [92 to 115]120 (15) [113 to 127]−17 [−26 to −7], p = 0.002
DLco (% pred)93 (2) [88 to 98]47 (27) [32 to 61]+46 [+32 to +61], p<0.0001
KCO (% pred)85 (5) [72 to 98]57 (29) [41 to 72]+28 [+12 to +45], p = 0.002
Pao2 (kPa)NA9.2 (1.4) [9.8 to 8.5]
Paco2 (kPa)NA5.5 (0.9) [5.9 to 5.0]
Vo2max (% pred)NA55 (7) [36 to 74]
Wrmax (% pred)NA45 (8) [22 to 67]
QMVC (kg)40.4 (6.2) [32.7 to 48]29.9 (8.9) [23.9 to 35.9]+10.5 [+1.9 to +19], p = 0.02
Q twitch tension (kg)10.2 (2.4) [7.2 to 13.2]8.5 (2.7) [6.7 to 10.2]+1.7 [−1.4 to +4.8], p = 0.238
Type I fibres (%)43 (10.6) [26 to 60]29 (7.4) [24 to 33]+14 [−1 to +30], p = 0.03
Type II fibres (%)57 (10.6) [40 to 74]71 (7.3) [66 to 76]−14 [−30 to +2], p = 0.03
  • Data are presented as mean (SD) and [95% CI].

  • BMI, body mass index; COPD, chronic obstructive pulmonary disease; DLco, carbon monoxide transfer; FEV1, forced expiratory volume in 1 s; FFMI, fat free mass index; FVC, forced vital capacity; KCO, Krogh transfer factor; MVC, maximal velocity contraction; NA, not available; Pao2, arterial oxygen partial pressure; Paco2, arterial carbon dioxide partial pressure; pred, predicted; Q, quadriceps; RV, residual volume; TLC, total lung capacity; Vo2max, peak exercise oxygen uptake; Wrmax, maximal mechanical power output.